Michael Chuong, Lead GI Radiation Oncologist at Miami Cancer Institute, shared on X:
“Excited our phase 1 trial of ablative reRT is open at the Miami Cancer Institute Research. .
- Based on our data (PMID: 35146215)
- 50 Gy/5 fx
- Primary/metastatic lesions in abdomen/pelvis
- GI abutment ok, not invasion
- Maybe reRT can be more than just palliative?”
Source: Michael Chuong/X